Mastek provides digital engineering and cloud transformation services, specializing in implementing and managing enterprise platforms like Oracle and Salesforce for government, healthcare, and financial services clients.
The company possesses switching costs and intangible assets derived from deep integration into critical national infrastructure, particularly within the UK public sector and NHS. This is corroborated by a high repeat business ratio of over 95% and stable net margins near 10%, though it lacks the scale-based cost advantages of larger Tier-1 competitors.
Management has prioritized strategic acquisitions to build out service lines like Salesforce and Data/AI, while maintaining a conservative debt profile and consistent dividend payouts. Recent focus has shifted toward internal AI-led productivity to protect margins against wage inflation.
The investment collapsed as the heavy concentration in the UK public sector turned from a tailwind into a trap. Budgetary austerity and shifting political priorities in Britain led to a prolonged slowdown in backlog consumption, while the company's lack of Tier-1 scale prevented it from competing on price against global giants. Simultaneously, the Middle East operations suffered from persistent geopolitical instability and uncollectible receivables, leading to massive write-offs. The 'strategic' acquisitions failed to integrate, and the business was caught in a pincer movement of wage inflation and eroding pricing power, causing margins to compress permanently below the cost of capital.
RichFakir rates Mastek Ltd's business quality as decent — 69/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Mastek Ltd is trading about 49% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Mastek Ltd is: Buy candidate. A decent business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of Mastek Ltd's fair value is about ₹2,813 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →